Anlon Healthcare’s Rs 121 crore IPO drew robust demand, subscribed 3.8 times by Day 3, with retail investors leading at 25.85 times. Despite a modest 5% grey market premium, analysts back the issue for its strong product pipeline, global presence, and long-term growth prospects.